These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9918249)

  • 1. Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity.
    D'Cruz D; Direskeneli H; Khamashta M; Hughes GR
    J Rheumatol; 1999 Jan; 26(1):103-9. PubMed ID: 9918249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum soluble CD4 and CD8 levels in polymyalgia rheumatica.
    Salvarani C; Boiardi L; Macchioni P; Casadei Maldini M; Mancini R; Beltrandi E; Rossi F; Portioli I
    J Rheumatol; 1994 Oct; 21(10):1865-9. PubMed ID: 7837152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8.
    Dooley MA; Cush JJ; Lipsky PE; Dawson DV; Pisetsky DS
    J Rheumatol; 1993 Nov; 20(11):1857-62. PubMed ID: 8308770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage.
    Schmitt WH; Csernok E; Kobayashi S; Klinkenborg A; Reinhold-Keller E; Gross WL
    Arthritis Rheum; 1998 Mar; 41(3):445-52. PubMed ID: 9506572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis.
    Nassonov EL; Samsonov MY; Tilz GP; Beketova TV; Semenkova EN; Baranov A; Wachter H; Fuchs D
    J Rheumatol; 1997 Apr; 24(4):666-70. PubMed ID: 9101499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D
    Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of soluble interleukin-2 receptor in patients with ANCA-associated vasculitis.
    Arranz O; Ara J; Rodríguez R; Saurina A; Mirapeix E; Darnell A
    J Nephrol; 2000; 13(1):59-64. PubMed ID: 10720216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum markers of T cell activation in relapses of Wegener's granulomatosis.
    Stegeman CA; Tervaert JW; Huitema MG; Kallenberg CG
    Clin Exp Immunol; 1993 Mar; 91(3):415-20. PubMed ID: 8443965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
    Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
    Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosis.
    Vinante F; Morosato L; Siviero F; Nadali G; Rigo A; Veneri D; de Sabata D; Vincenzi C; Chilosi M; Semenzato G
    Haematologica; 1994; 79(5):413-9. PubMed ID: 7843627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
    Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
    J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiendothelial cell antibodies in patients with Wegener's granulomatosis: prevalence and correlation with disease activity and manifestations.
    Sebastian JK; Mahr AD; Ahmed SS; Stone JH; Romay-Penabad Z; Davis JC; Hoffman GS; McCune WJ; St Clair EW; Specks U; Spiera R; Pierangeli S; Merkel PA
    J Rheumatol; 2007 May; 34(5):1027-31. PubMed ID: 17444585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble CD4, CD8 and interleukin-2 receptor levels in patients with acute cytomegalovirus mononucleosis syndrome.
    Marcante R; Cavedon G
    Allergol Immunopathol (Madr); 1991; 19(3):99-102. PubMed ID: 1665953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
    Salvarani C; Macchioni P; Boiardi L; Rossi F; Casadei Maldini M; Mancini R; Beltrandi E; Spacca C; Lodi L; Portioli I
    J Rheumatol; 1992 Jul; 19(7):1100-6. PubMed ID: 1512765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides.
    Boehme MW; Schmitt WH; Youinou P; Stremmel WR; Gross WL
    Am J Med; 1996 Oct; 101(4):387-94. PubMed ID: 8873509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic variables in normal pregnancy and spontaneous abortion.
    Matalliotakis I; Neonaki M; Giannakopoulou C; Goumenou A; Hassan E; Koumantakis E
    Int J Fertil Womens Med; 1998; 43(5):262-6. PubMed ID: 9863620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum markers of T-cell activation in relapses of Wegener's granulomatosis.
    Stegeman CA; Tervaert JW; Huitema MG; Kallenberg CG
    Adv Exp Med Biol; 1993; 336():389-92. PubMed ID: 8296642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus.
    Srivastava MD; Rossi TM; Lebenthal E
    Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):21-6. PubMed ID: 7735726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of markers of endothelial cell damage and markers of activated coagulation in patients with systemic necrotizing vasculitis.
    Hergesell O; Andrassy K; Nawroth P
    Thromb Haemost; 1996 Jun; 75(6):892-8. PubMed ID: 8822582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
    Peng Q; Wu Q; Chen CH; Hong H; Zhang LY
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.